Spreng Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Sell |
892
-15
| -2% | -$6.08K | 0.15% | 63 |
|
|
2025
Q1 | $451K | Hold |
907
| – | – | 0.2% | 55 |
|
|
2024
Q4 | $472K | Hold |
907
| – | – | 0.21% | 57 |
|
|
2024
Q3 | $561K | Sell |
907
-356
| -28% | -$220K | 0.26% | 52 |
|
|
2024
Q2 | $698K | Buy |
1,263
+15
| +1% | +$8.3K | 0.36% | 47 |
|
|
2024
Q1 | $725K | Sell |
1,248
-6
| -0.5% | -$3.49K | 0.39% | 47 |
|
|
2023
Q4 | $666K | Sell |
1,254
-19
| -1% | -$10.1K | 0.42% | 47 |
|
|
2023
Q3 | $644K | Buy |
1,273
+25
| +2% | +$12.7K | 0.47% | 45 |
|
|
2023
Q2 | $651K | Buy |
1,248
+50
| +4% | +$26.1K | 0.51% | 43 |
|
|
2023
Q1 | $690K | Buy |
1,198
+35
| +3% | +$20.2K | 0.6% | 43 |
|
|
2022
Q4 | $640K | Sell |
1,163
-275
| -19% | -$151K | 0.55% | 43 |
|
|
2022
Q3 | $729K | Sell |
1,438
-30
| -2% | -$15.2K | 0.65% | 41 |
|
|
2022
Q2 | $813K | Sell |
1,468
-165
| -10% | -$91.4K | 0.61% | 42 |
|
|
2022
Q1 | $964K | Sell |
1,633
-84
| -5% | -$49.6K | 0.59% | 41 |
|
|
2021
Q4 | $1.15M | Hold |
1,717
| – | – | 0.66% | 38 |
|
|
2021
Q3 | $983K | Hold |
1,717
| – | – | 0.63% | 39 |
|
|
2021
Q2 | $866K | Buy |
1,717
+97
| +6% | +$48.9K | 0.56% | 44 |
|
|
2021
Q1 | $739K | Buy |
1,620
+35
| +2% | +$16K | 0.51% | 45 |
|
|
2020
Q4 | $738K | Sell |
1,585
-302
| -16% | -$141K | 0.58% | 39 |
|
|
2020
Q3 | $833K | Sell |
1,887
-18
| -0.9% | -$7.95K | 0.79% | 35 |
|
|
2020
Q2 | $690K | Sell |
1,905
-125
| -6% | -$45.3K | 0.7% | 39 |
|
|
2020
Q1 | $576K | Sell |
2,030
-160
| -7% | -$45.4K | 0.66% | 38 |
|
|
2019
Q4 | $711K | Buy |
+2,190
| New | +$711K | 0.66% | 40 |
|